Global Hemophilia Market Set to Reach USD 21.24 Billion by 2032, Driven by Gene Therapy Advancements and Expanding Treatment Infrastructure Rising Demand for Advanced Bleeding Disorder Treatments Fuels Growth Across Global Healthcare Markets The global Hemophilia Market is witnessing remarkable growth as healthcare systems worldwide focus on improving diagnosis, treatment accessibility, and...